Daclatasvir Dihydrochloride and Immune Globulin (Human)-klhw (Subcutaneous)
Determining the interaction of Daclatasvir Dihydrochloride and Immune Globulin (Human)-klhw (Subcutaneous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: immune globulin subcutaneous
Brand name: Cutaquig, Cuvitru, Hizentra, Vivaglobin, Xembify
Synonyms: Immune globulin (subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Immune globulin (intramuscular) IGIM
- Daclatasvir Dihydrochloride-Immune globulin (intravenous) IGIV
- Daclatasvir Dihydrochloride-Immune globulin and hyaluronidase Subcutaneous
- Daclatasvir Dihydrochloride-Immune Globulin Injection (IM)
- Daclatasvir Dihydrochloride-Immune Globulin Injection (IV)
- Daclatasvir Dihydrochloride-Immune Globulin Injection (Subcutaneous or IV)
- Immune Globulin (Human)-klhw (Subcutaneous)-Daclizumab
- Immune Globulin (Human)-klhw (Subcutaneous)-Daclizumab Subcutaneous
- Immune Globulin (Human)-klhw (Subcutaneous)-Dacogen
- Immune Globulin (Human)-klhw (Subcutaneous)-Dacomitinib
- Immune Globulin (Human)-klhw (Subcutaneous)-Dactinomycin
- Immune Globulin (Human)-klhw (Subcutaneous)-Dactinomycin Injection